BioGend Therapeutics Co., Ltd. (6733.TWO)
TWD 25.75
(-9.81%)
TWD 25.75
(-9.81%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 93.71 Million TWD | 3.49% |
| 2022 | 90.55 Million TWD | 12.61% |
| 2021 | 80.41 Million TWD | 287.11% |
| 2020 | 20.77 Million TWD | 15.45% |
| 2019 | 17.99 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 63.47 Million TWD | -3.32% |
| 2024 Q1 | 65.65 Million TWD | -29.94% |
| 2023 Q4 | 93.71 Million TWD | 27.37% |
| 2023 FY | 93.71 Million TWD | 3.49% |
| 2023 Q3 | 73.57 Million TWD | -8.7% |
| 2023 Q2 | 80.58 Million TWD | 3.14% |
| 2023 Q1 | 78.13 Million TWD | -13.72% |
| 2022 Q4 | 90.55 Million TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 83.939% |
| Level Biotechnology Inc. | 273.2 Million TWD | 65.698% |
| Sagittarius Life Science Corp | 137.82 Million TWD | 32.005% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | 52.543% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 92.942% |
| GlycoNex Incorporation | 276.39 Million TWD | 66.095% |
| VBI | 21.25 Million TWD | -340.986% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | 70.127% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 81.791% |
| Visgeneer Inc. | 185.6 Million TWD | 49.509% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 92.918% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 87.215% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | 21.814% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 95.828% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -1316.047% |
| Enimmune corporation | 173.46 Million TWD | 45.975% |
| TaiRx, Inc. | 60.62 Million TWD | -54.58% |
| CHO Pharma, Inc. | 110.83 Million TWD | 15.445% |
| EirGenix Inc. | 1.14 Billion TWD | 91.816% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | 16.313% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | 81.712% |
| Lin BioScience, Inc. | 167.73 Million TWD | 44.128% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | -48.672% |
| Bio Preventive Medicine Corp. | 124.72 Million TWD | 24.866% |
| Lukas Biomedical Inc. | 161.05 Million TWD | 41.814% |
| RBC Bioscience Corporation | 513.08 Million TWD | 81.735% |
| BiOptic Inc. | 170.56 Million TWD | 45.056% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | -122.292% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -302.984% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -249.51% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 90.385% |
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -1239.92% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -341.506% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 74.557% |
| Neith Corporation | 17.43 Million TWD | -437.567% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -1075.539% |
| NaviFUS Corp. | 53.4 Million TWD | -75.491% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 80.537% |
| Sinew Pharma Inc. | 39.71 Million TWD | -135.972% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -61.467% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 74.288% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 58.842% |
| AP Biosciences Inc | 106.65 Million TWD | 12.129% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 97.345% |
| 3D Global Biotech Inc. | 30.68 Million TWD | -205.446% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | 52.184% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 93.927% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 89.184% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -910.285% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | -67.907% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 59.772% |
| TCI GENE Inc. | 155.54 Million TWD | 39.752% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -267.391% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | -102.954% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 71.47% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | -44.426% |
| PharmaEngine, Inc. | 91 Million TWD | -2.976% |
| Savior Lifetec Corporation | 457.95 Million TWD | 79.537% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | 15.527% |
| OBI Pharma, Inc. | 650.44 Million TWD | 85.592% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | 76.021% |
| Acepodia, Inc. | 384.47 Million TWD | 75.625% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | -9.539% |